Standout Papers

The Decline of the Gastropod <i>Nucella Lapillus</i> Around South-West England: Evidence for ... 1986 2026 1999 2012 608
  1. The Decline of the Gastropod Nucella Lapillus Around South-West England: Evidence for the Effect of Tributyltin from Antifouling Paints (1986)
    G. W. Bryan, Peter Gibbs et al. Journal of the Marine Biological Association of the United Kingdom
  2. Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer (2011)
    Ben Tran, Scott Kopetz et al. Cancer
  3. Critical appraisal of the evidence for tributyltin-mediated endocrine disruption in mollusks (1998)
    Peter Matthiessen, Peter Gibbs Environmental Toxicology and Chemistry
  4. Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF -Mutated Colorectal Cancer (2015)
    Scott Kopetz, Jayesh Desai et al. Journal of Clinical Oncology
  5. Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study (2022)
    Luis A. Díaz, Kai‐Keen Shiu et al. The Lancet Oncology
  6. Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer (2015)
    Jeanne Tie, Isaac Kinde et al. Annals of Oncology
  7. The use of the dog-whelk, Nucella lapillus, as an indicator of tributyltin (TBT) contamination (1987)
    Peter Gibbs, G. W. Bryan et al. Journal of the Marine Biological Association of the United Kingdom
  8. Reproductive Failure in Populations of the Dog-Whelk, Nucella Lapillus, Caused by Imposex Induced by Tributyltin from Antifouling Paints (1986)
    Peter Gibbs, G. W. Bryan Journal of the Marine Biological Association of the United Kingdom

Immediate Impact

19 by Nobel laureates 20 from Science/Nature 77 standout
Sub-graph 1 of 21

Citing Papers

Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Standout
Colorectal cancer
2024 Standout
10 intermediate papers

Works of Peter Gibbs being referenced

Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study
2022 Standout
PIK3CA, BRAF, and PTEN Status and Benefit from Cetuximab in the Treatment of Advanced Colorectal Cancer—Results from NCIC CTG/AGITG CO.17
2013
and 8 more

Author Peers

Author Last Decade Papers Cites
Peter Gibbs 5869 2172 2694 4165 3006 497 15.3k
Meng Li 1492 1304 748 5964 920 607 17.2k
Sabine Eckhardt 3780 1620 749 3289 2064 274 14.6k
J. Carl Barrett 6680 4465 1643 10556 686 310 20.8k
Hajime Watanabe 1712 1655 766 3223 1895 319 10.4k
Shin Takahashi 808 353 268 716 6519 331 10.9k
Randy L. Jirtle 1709 1597 590 9237 1683 204 18.1k
Yu Chen 1690 1248 694 6657 4845 603 21.0k
Hiroshi Miyamoto 1783 3561 395 3450 350 405 11.7k
Charles F. Lynch 7913 3887 2917 3014 2469 429 26.9k
Roy E. Shore 3352 2313 1161 2206 985 226 15.5k

All Works

Loading papers...

Rankless by CCL
2026